Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640455-19-000036
Filing Date
2019-05-08
Accepted
2019-05-08 12:44:53
Documents
70
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q jnce0331201910-q.htm 10-Q 1101328
2 EXHIBIT 10.1 jnce03312019exhibit101.htm EX-10.1 16069
3 EXHIBIT 31.1 jnce03312019exhibit311.htm EX-31.1 10661
4 EXHIBIT 31.2 jnce03312019exhibit312.htm EX-31.2 10669
5 EXHIBIT 32.1 jnce03312019exhibit321.htm EX-32.1 11712
  Complete submission text file 0001640455-19-000036.txt   5518493

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT jnce-20190331.xml EX-101.INS 1098853
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnce-20190331.xsd EX-101.SCH 44158
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jnce-20190331_cal.xml EX-101.CAL 69043
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnce-20190331_def.xml EX-101.DEF 197251
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnce-20190331_lab.xml EX-101.LAB 575056
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnce-20190331_pre.xml EX-101.PRE 342219
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

EIN.: 454870634 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37998 | Film No.: 19805926
SIC: 2836 Biological Products, (No Diagnostic Substances)